Stivarga (regorafenib)

pCPA File Number: 20794
Negotiation Status:
Concluded with an LOI
Indication(s):
Gastrointestinal Stromal Tumours
Sponsor/Manufacturer:
Bayer Inc.
CDA-AMC Project Number:
PC0034-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: